Navigating insurance coverage for GLP-1 drugs prescribed for weight loss can feel overwhelming, especially with so many variations across plans. Based on my experience guiding clients through the healthcare landscape—and my own journey in healthcare, both here and abroad—clarity and confidence are essential. In the US, most health plans have traditionally covered these medications when prescribed for diabetes or related conditions. However, for weight-loss-only prescriptions, coverage is much less common and often depends on plan type and formulary rules. Many insurers require prior authorization and set minimum BMI thresholds before approving these medications for weight management. Individual market plans rarely offer coverage for weight-loss use, while employer-sponsored plans are mixed—about 60% cover diabetes treatment, and just 35% cover both diabetes and weight loss. The federal senior health program currently excludes weight-loss-only use from its standard drug benefit, though a new pilot allows access to specific GLP-1 medications for $50 per month. State-federal coverage is also inconsistent. For anyone considering these medications, it’s important to carefully review your plan’s rules, appeal if necessary, and keep an eye out for updates as some programs continue to evolve. My goal is always to help you make informed decisions about your health coverage, so you feel empowered and supported every step of the way.